Citigroup Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its price target boosted by Citigroup from $83.00 to $85.00 in a research note released on Thursday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock.

Other analysts have also recently issued research reports about the stock. Bank of America increased their price objective on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Oppenheimer increased their price objective on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Wall Street Zen cut shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Corteva in a report on Wednesday, April 22nd. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and an average price target of $86.95.

Corteva Trading Down 3.2%

Corteva stock opened at $79.14 on Thursday. The firm’s 50-day moving average is $80.68 and its 200-day moving average is $72.61. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.47. Corteva has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a market cap of $53.13 billion, a P/E ratio of 46.55, a PEG ratio of 2.81 and a beta of 0.59.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter last year, the company earned $1.13 EPS. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts expect that Corteva will post 3.62 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.15% of the company’s stock.

Hedge Funds Weigh In On Corteva

Large investors have recently bought and sold shares of the stock. Activest Wealth Management increased its stake in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares during the period. JPL Wealth Management LLC acquired a new position in Corteva during the 3rd quarter valued at about $25,000. Westfuller Advisors LLC grew its stake in shares of Corteva by 2,764.3% in the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after purchasing an additional 387 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in shares of Corteva in the 4th quarter worth approximately $27,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of Corteva in the 4th quarter worth approximately $28,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Q1 results were strong — Corteva beat expectations, reaffirmed its 2026 outlook and said it remains on track for the planned 4Q-2026 separation, underpinning earnings visibility and growth prospects. Corteva Delivers Strong 1Q 2026 (Finanznachrichten)
• Positive Sentiment: Jefferies raised its price target to $97 (about ~21.6% upside vs. current levels), signaling bullish analyst conviction that could support further upside if investors follow. Jefferies raises PT to $97 (MarketScreener)
• Positive Sentiment: UBS lifted its price target to $90 (though it kept a “neutral” rating), which increases implied upside and may support buying interest among investors focused on valuation. UBS raises PT to $90 (Benzinga)
• Positive Sentiment: Citigroup raised its target to $85 while maintaining a “neutral” rating — another upward revision that suggests analysts are incrementally more constructive on Corteva’s outlook. Citigroup raises PT to $85 (TickerReport)
• Neutral Sentiment: Corteva management will speak at the BMO Global Farm to Market conference (May 14). Investor presentations and Q&A could provide incremental color but are routine events. Corteva to Participate in BMO Conference (PRNewswire)
• Neutral Sentiment: Full Q1 earnings call transcript and presentation are available for deeper detail on margins, guidance and separation timing — useful for active investors but not new headline news. Q1 Earnings Transcript (Yahoo) Earnings Call Transcript (Seeking Alpha)
• Negative Sentiment: BNP Paribas raised its target only to $77, which implies downside versus current levels and signals at least one analyst thinks upside is limited — a potential headwind for sentiment. BNP Paribas raises PT to $77 (MarketScreener)

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.